EMPALIX-S 25/100

EMPALIX-S 25/100 contains Empagliflozin 25 mg + Sitagliptin 100 mg, a strong dual therapy for effective management of type 2 diabetes. Empagliflozin works by removing excess glucose through urine, while Sitagliptin enhances insulin release and controls glucose production. This combination provides better and sustained glycemic control, along with added benefits like weight reduction and cardiovascular protection, making it suitable for patients needing intensified therapy.